Ticker
PEN
Analysis
Penumbra, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to PEN.
Penumbra, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to PEN.
PEN
Stock
$12.61B
Health Technology
Medical Specialties
USD
Penumbra, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
Penumbra Expands CAVT for Stroke to Europe with CE Mark for
Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the first quarter ended March 31, 2026.
Penumbra, Inc. (NYSE: PEN) announced 90-day results of the landmark STORM-PE randomized controlled trial (RCT), which found that patients with acute intermediate-high risk pulmo...
Penumbra Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penumbra, Inc. -
Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the fourth quarter and full year ended December 31, 2025.
Review valuation context for Penumbra, Inc..
Review future growth context for Penumbra, Inc..
Review past performance context for Penumbra, Inc..
Review financial health context for Penumbra, Inc..
Review dividend context for Penumbra, Inc..
Review management context for Penumbra, Inc..
Review ownership context for Penumbra, Inc..
Review other information context for Penumbra, Inc..
Review community context for Penumbra, Inc..